Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Position Trimmed by Rhumbline Advisers

Rhumbline Advisers lessened its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHCFree Report) by 0.9% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 250,874 shares of the company’s stock after selling 2,163 shares during the quarter. Rhumbline Advisers owned approximately 0.27% of Acadia Healthcare worth $7,606,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Lindbrook Capital LLC grew its stake in shares of Acadia Healthcare by 1,342.0% in the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company’s stock valued at $29,000 after buying an additional 671 shares in the last quarter. Signaturefd LLC grew its stake in shares of Acadia Healthcare by 460.6% in the 4th quarter. Signaturefd LLC now owns 1,222 shares of the company’s stock valued at $48,000 after buying an additional 1,004 shares in the last quarter. Quadrant Capital Group LLC grew its stake in shares of Acadia Healthcare by 287.1% in the 4th quarter. Quadrant Capital Group LLC now owns 1,258 shares of the company’s stock valued at $50,000 after buying an additional 933 shares in the last quarter. State of Wyoming bought a new stake in shares of Acadia Healthcare in the 4th quarter valued at approximately $56,000. Finally, Covestor Ltd grew its stake in shares of Acadia Healthcare by 27.2% in the 4th quarter. Covestor Ltd now owns 1,450 shares of the company’s stock valued at $58,000 after buying an additional 310 shares in the last quarter.

Acadia Healthcare Stock Up 2.8%

ACHC opened at $22.61 on Wednesday. Acadia Healthcare Company, Inc. has a 1-year low of $20.36 and a 1-year high of $82.41. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The stock has a market capitalization of $2.08 billion, a price-to-earnings ratio of 7.41, a P/E/G ratio of 1.46 and a beta of 0.94. The business has a 50 day moving average of $24.07 and a 200-day moving average of $33.50.

Acadia Healthcare (NASDAQ:ACHCGet Free Report) last posted its quarterly earnings data on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.05. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The company had revenue of $770.51 million during the quarter, compared to analysts’ expectations of $769.90 million. During the same period in the prior year, the business earned $0.84 earnings per share. Acadia Healthcare’s revenue for the quarter was up .3% compared to the same quarter last year. As a group, sell-side analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Wall Street Analyst Weigh In

Several brokerages recently commented on ACHC. Wall Street Zen raised Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Thursday, May 22nd. Bank of America decreased their target price on Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating for the company in a research report on Friday, February 28th. Guggenheim initiated coverage on Acadia Healthcare in a research report on Wednesday, April 9th. They set a “buy” rating and a $36.00 target price for the company. Royal Bank of Canada decreased their target price on Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating for the company in a research report on Monday, March 3rd. Finally, Barclays decreased their target price on Acadia Healthcare from $35.00 to $28.00 and set an “equal weight” rating for the company in a research report on Wednesday, May 14th. Five equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $47.94.

View Our Latest Stock Analysis on ACHC

Acadia Healthcare Profile

(Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Featured Stories

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHCFree Report).

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.